Trial of JYB1904 in Chronic Spontaneous Urticaria.

NCT06509334 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Spontaneous Urticaria

Interventions

DRUG: JYB1904
DRUG: JYB1904
DRUG: Omalizumab

Sponsor

Jemincare